Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5182_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
396 Wild Edible Plants
Wang, K., Bao, L., Qi, Q/ , Zhao, F., Ma, K., Pei, Y., Liu, H. (2015). Erinacerins C- L, isoindolin-
1- ones with α- glucosidase inhibitory activity from cultures of the medicinal mushroom Hericium erinaceus. Journal of Natural Products, 78(1), 146– 154. https:// doi.org/ 10.1021/ np5004 388
Wang, S.J., Li, Y.X., Bao, L., Han, J.J., Yang, X.L., Li, H.R., Wang, Y.Q., Li, S.J., & Liu,
H.W. (2012). Eryngiolide A, a cytotoxic macrocyclic diterpenoid with an unusual cyclododecane core skeleton produced by the edible mushroom Pleurotus eryngii. Organic Letters, 14(14), 3672– 3675. https:// doi.org/ 10.1021/ ol3015 19m
Wang, Y., Huang, X., & Nie, S. (2018). Novel prospective of wild mushroom polysaccharides
as potential prebiotics. In B. Singh, Lallawmsanga, & A. Passari (Eds.), Biology of macrofungi. Fungal biology, (pp. 211– 226). Springer, Cham. https:// doi.org/ 10.1007/ 978­3- 030- 02622- 6_ 10
Wang, Z., Qu, K., Zhou, L., Ren, L., Ren, B., Meng, F., Yu, W., Wang, H., & Fan, H. (2021).
Apaf1 nanoLuc biosensors identied lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications, 577, 45– 51. https:// doi.org/ 10.1016/ j.bbrc.2021.08.030
Wei, L., Wang, W., Hou, Y., Wang, X., Liu, Y., Xie, X., Li, X., Wang, T., & Jing, B. (2023).
Assessment of the quality characteristics of Stropharia rugosoannulata subjected to ve different drying methods. Journal of Food Processing and Preservation, article 2518620, 1– 12. https:// doi.org/ 10.1155/ 2023/ 2518 620
Wu, F., Tang, J., Pei, F., Wang, S., Chen, G., Hu, Q., & Zhao, L. (2014). The inuence of
four drying methods on nonvolatile taste components of White Hypsizygus marmoreus. European Food Research and Technology, 240(4), 823– 830. https:// doi.org/ 10.1007/ s00 217- 014- 2388- 4
Wu, J., Kobori, H., Kawaide, M., Suzuki, T., Choi, J. H., Yasuda, N., Noguchi, K., Matsumoto,
T., Hirai, H., & Kawagishi, H. (2013). Isolation of bioactive steroids from the Stropharia
rugosoannulata mushroom and absolute conguration of Strophasterol B. Bioscience, Biotechnology, and Biochemistry, 77(8), 1779– 1781. https:// doi.org/ 10.1271/ bbb.130 216
Wu, J., Tokuyama, S., Nagai, K., Yasuda, N., Noguchi, K., Matsumoto, T., Hirai, H., & Kawagishi,
H. (2012). Strophasterols A to D with an unprecedented steroid skeleton: From the mush­room Stropharia rugosoannulata. Angewandte Chemie, 124(43), 10978– 10980. https:// doi. org/ 10.1002/ ange.201205 351
Wu, L., Liu, X., Hu, R., Chen, Y., Xiao, M., Liu, B., & Zeng, F. (2022). Prebiotic Agrocybe
cylindracea crude polysaccharides combined with Lactobacillus rhamnosus GG postpone aging- related oxidative stress in mice. Food & Function, 13(3), 1218– 1231. https:// doi.org/
10.1039/ D1F O020 79J
Xu, Q., Wang, H., Li, T., Chen, L., Zheng, B., & Liu, R. H. (2020). Comparison of phenolics,
antioxidant, and antiproliferative activities of two Hypsizygus marmoreus varieties. Journal of Food Science, 85(7), 2227– 2235. https:// doi.org/ 10.1111/ 1750- 3841.15173
Xue, Z., Li, J., Cheng, A., Yu, W., Zhang, Z., Kou, X., & Zhou, F. (2015). Structure identi-
cation of triterpene from the mushroom Pleurotus eryngii with inhibitory effects against breast cancer. Plant Foods for Human Nutrition, 70(3), 291– 296. https:// doi.org/ 10.1007/ s11 130- 015- 0492- 7
Xue, Z., Ma, Q., Chen, Y., Lu, Y., Wang, Y., Jia, Y., Zhang, M., & Chen, H. (2020). Structure
characterization of soluble dietary ber fractions from mushroom Lentinula edodes (Berk.) Pegler and the effects on fermentation and human gut microbiota in vitro. Food Research International, 129, 108870. https:// doi.org/ 10.1016/ j.food res.2019.108 870
Yan, Q.- X., Huang, M.- X., Sun, P., Cheng, S., Zhang, Q., & Dai, H. (2020). Steroids, fatty acids and
ceramide from the mushroom Stropharia rugosoannulata Farlow apud Murrill. Biochemical Systematics and Ecology, 88, 103963. https:// doi.org/ 10.1016/ j.bse.2019.103 963
Edible and Medicinal Mushrooms as an Eco-Friendly Source of Food 397
Yang, Z., Xu, J., Fu, Q., Fu, X., Shu, T., Bi, Y., & Song, B. (2013). Antitumor activity of a poly-
saccharide from Pleurotus eryngii on mice bearing renal cancer. Carbohydrate Polymers, 95(2), 615– 620. https:// doi.org/ 10.1016/ j.carb pol.2013.03.024
Yao, F., Gao, H., Yin, C. M., Shi, D. F., & Fan, X. Z. (2023). Effect of different cooking methods
on the bioactive components, color, texture, microstructure, and volatiles of Shiitake mushrooms. Foods, 12(13), 2573. https:// doi.org/ 10.3390/ foods1 2132 573
Ye, K., Fu, C., Ma, S., Du, H., Chen, S., Liu, D., Ma, G., & Xiao, H. (2023). Comprehensive
assessment of Hypsizygus marmoreus polysaccharides through simulated digestion and gut microbiota fermentation in vitro. Food Hydrocolloids, 144, 108989. https:// doi.org/
10.1016/ j.food hyd.2023.108 989
Yu, Q., Guo, M., Zhang, B., Wu, H., Zhang, Y., & Zhang, L. (2020). Analysis of nutritional com-
position in 23 kinds of edible fungi. Journal of Food Quality, 2020, 1– 9. https:// doi.org/
10.1155/ 2020/ 8821 315
Zan, X., Cui, F., Li, Y., Yang, Y., Wu, D., Sun, W., & Ping, L. (2015). Hericium erinaceus
polysaccharide- protein HEG- 5 inhibits SGC- 7901 cell growth via cell cycle arrest and apoptosis. International Journal of Biological Macromolecules, 76, 242−253. https:// doi. org/ 10.1016/ j.ijbio mac.2015.01.060
Zhai, X., Zhao, A., Geng, L., & Xu, C. (2013). Fermentation characteristics and hypogly-
cemic activity of an exopolysaccharide produced by submerged culture of Stropharia rugosoannulata. Annals of Microbiology, 63(3), 1013– 1020. https:// doi.org/ 10.1007/ s13 213- 012- 0555- z
Zhang, B., Li, Y., Zhang, F., Linhardt, R. J., Zeng, G., & Zhang, A. (2020). Extraction, structure
and bioactivities of the polysaccharides from Pleurotus eryngii: A review. International Journal of Biological Macromolecules, 150, 1342– 1347. https:// doi.org/ 10.1016/ j.ijbio mac.2019.10.144
Zhang, J., Feng, N., Liu, Y., Zhang, H., Yang, Y., Liu, L., & Feng, J. (2022). Bioactive compounds
from medicinal mushrooms. Advances in Biochemical Engineering/ Biotechnology, 184, 219– 268. https:// doi.org/ 10.1007/ 10_ 2 022_ 202
Zhang, M., Zhang, Y., Zhang, L., & Tian, Q. (2019). Mushroom polysaccharide lentinan for
treating different types of cancers: A review of 12 years clinical studies in China. Progress in Molecular Biology and Translational Science, 163, 297– 328. https:// doi.org/ 10.1016/ BS.PMBTS.2019.02.013
Zhang, W., Tian, G., Geng, X., Zhao, Y., Ng, T., Zhao, L., & Wang, H. (2014). Isolation and
characterization of a novel lectin from the edible mushroom Stropharia rugosoannulata. Molecules, 19(12), 19880– 19891. https:// doi.org/ 10.3390/ mol ecul es19 1219 880
Zhou, G., Liu, H., Yuan, Y., Wang, Q., Wang, L., & Wu, J. (2024). Lentinan progress in inamma-
tory diseases and tumor diseases. European Journal of Medical Research, 29(1), 8. https:// doi.org/ 10.1186/ s40 001- 023- 01585- 7
Regulation of the Biological Activity
14
of Medicinal Macromycetes Using Low- Intense Quasi­Monochromatic and Laser Light
Oksana Mykchaylova, Margarita Lomberg, Alexander Galkin, and Natalia Poyedinok
14.1 INTRODUCTION
Searching for new sources of physiologically active compounds to obtain functional and safe products is one of the most critical tasks of modern biotechnology (Badalyan & Rapior, 2020; Deshmukh et al., 2022; Hyde et al., 2019). Edible and medicinal macromycetes, in addition to their nutritional value and bioavailability, represent a rich but largely underutilized resource of useful natural compounds with diverse pharmaco­logical activities (Hobbs, 2023; Lu et al., 2020; Martinez- Medina et al., 2021; Rangel­Vargas et al., 2021; Song et al., 2020; Stabnikova et al., 2024; Venturella et al., 2021). Considering that edible mushrooms are producers of valuable metabolites, prospects are opening up for their use in the development of new functional foods and nutraceuticals
398
DOI: 10.1201/9781003486794-14
Regulation of the Biological Activity of Medicinal Macromycetes 399
without serious problems regarding the safety of their use (Bell et al., 2022; Cohen et al., 2014; Giavasis, 2014; Ivanov et al., 2021; Rangsinth et al., 2023; Valverde et al., 2015). Depending on the purpose of use, various products based on edible and medicinal mushrooms have been developed, which can be broadly divided into cat­egories: functional foods, dietary supplements, nutraceuticals, and designer foods, including probiotics and prebiotics, which can provide benecial effects on health espe­cially by frequent human consumption (Kour et al., 2022; Morris et al., 2016; Niego et al., 2021, 2023; Rangel- Vargas et al., 2021) (Figure 14.1).
Although edible and medicinal mushrooms have been used by humans for thousands of years, it is only in recent decades that mushroom consumption has increased signi­cantly, mainly due to the growing awareness that a stable and balanced diet plays a key role in the normal functioning and the maintenance of health (Reis et al., 2017). According to Food and Agriculture Organization Statistical (FAOSTAT) data, the current global mushroom output trend is rising, with a global mushroom production of 43 million metric tons in 2018– 2019. Mushroom consumption is expected to rise,
FIGURE 14.1 Graphical representation of the use of edible and medicinal mushroom­based products.
400 Wild Edible Plants
indicating a continuous upward trend in mushroom production. The global mushroom market was valued at USD 45.3 billion in 2020 and is predicted to increase at a com­pound annual growth rate of 7% from 2022 to 2027 (Hamza et al., 2024; Niego et al., 2021, 2023).
Currently, nutrition is considered a fundamental basis for maintaining human health and development throughout life. Moreover, it is very important to have a proper diet and sufcient nutrients for physical growth, mental development, performance and productivity, health, and well- being. From this point of view, edible and medicinal mushrooms can be considered functional and safe food products.
Functional foods are regular or everyday foods consumed as part of a normal daily diet. They must consist of naturally occurring components (perhaps in unnatural concentrations or found in foods that do not normally contain them). Functional foods have a positive impact on target body functions beyond their nutritional value, improving well- being and quality of life and/ or reducing the risk of diseases (El- Sohaimy, 2012).
Fresh edible and medicinal mushrooms and their dried powders, aqueous extracts, concentrates, and bioactive compounds can be incorporated into foods to develop for­tied functional foods with the aim to substitute meat, fat, our, minerals, phosphates, and antioxidants in addition to contributing long shelf- life and low- cost production. Bakery, meat, dairy, fermented, fruit and vegetable, traditional products, and beverages have already been studied in vitro to present value- added and mushroom- based func- tional foods. In these studies, some changes in the nutritional, sensorial, textural, and pharmacological properties of novel value- added products were observed (Bulam et al., 2022; Das et al., 2021; Dorin and Melinda, 2021; Gonzales et al., 2020; Kumar et al., 2021; Kumaresan et al., 2022; Reis et al., 2017; Rangel- Vargas et al., 2021; Simakhina et al., 2022; Stabnikova et al., 2024; Yurchak & Sharkova, 2022).
Due to the high bioactive potential of edible and medicinal mushrooms, as well as the growing interest in natural medicines for the “treatment” of various physiological disorders, a new and specic term is now recognized: “mushroom nutraceuticals”, which should not be confused with general nutraceuticals, functional foods’ nutrition, and/ or general purpose food products or pharmaceuticals (Reis et al., 2017). The word “mushroom nutraceuticals” has been devised by Chang and Buswell (1996) and can be dened as rened or partially dened extractives from both mycelium or fruit bodies, frequently ingested in the form of capsules as a dietary supplement and symbolize an important constituent of the expanding mushroom biotechnology industry (Kour et al.,
2022). Mushroom nutraceuticals include puried extracts from fruiting bodies, puried polysaccharides, and dried mycelium biomass or mushrooms, which are consumed in the form of capsules, tablets, powder, syrup, and solution (Kour et al., 2022; Hozova et al., 2004; Reis et al., 2017). Mushroom nutraceuticals contain the following:
lipids, especially unsaturated fatty acids;
vitamins such as vitamins E, D, and vitamin C;
proteins, peptides, and amino acids, including lectins, leucine, and valine;
carbohydrates, especially polysaccharides such as lentinan.
Due to the presence of a wide range of bioactive compounds in mushrooms, they have great potential for the production of new nutraceutical formulations. However, despite the recognition of the enormous potential of edible and medicinal mushrooms as the
Regulation of the Biological Activity of Medicinal Macromycetes 401
basis of such formulations, there remain some unresolved issues affecting their prep­aration and subsequent marketing, such as issues of safety, standardization, regulation, efcacy, and mechanism of action (Kour et al., 2022).
Thus, the role of functional foods is primarily related to disease risk reduction rather than disease prevention, while nutraceuticals are typically consumed to promote well- being through the prevention and/ or treatment of diseases and/ or disorders (Reis et al., 2017; El- Sohaimy, 2012). Additionally, nutraceuticals should not be confused with medications, which are administered in precise doses under medical supervision. Because functional foods and nutraceuticals have properties found in foods and drugs, they are considered to straddle the boundary between conventional foods and drugs (Reis et al., 2017).
Sometimes this concept is also misused to describe another food concept the “dietary supplement”. Dietary supplements have essentially a feed function, taking the form of medicines (pills or capsules). Once they take the form of medicines and are not consumed as traditional food in the daily diet, they cannot be regarded as functional foods (Reis et al., 2017). Mushroom dietary supplements on the market are presented in the following forms:
powders from cultivated fruiting bodies, aqueous or alcoholic extracts of these fruiting bodies;
dried and crushed preparations from a combination of substrate, mycelium, and mushrooms primordia;
biomass or extracts from mycelium obtained by deep cultivation in fermenters or bioreactors;
dried fruiting bodies of wild mushrooms in the form of capsules or tablets; spores and their extracts (Kour et al., 2022; Reis et al., 2017).
One of the advantages of using mushroom- based food additives is their safety. Most of the mushrooms that are used in dietary supplements are cultivated on an industrial scale under strictly controlled conditions. Industrial strains of mushrooms undergo strict taxonomic control, are easily propagated in vitro, and are capable of growing as myce­lial biomass in submerged cultures. Growing medicinal mushrooms under standard conditions make it possible to control and intensify the synthesis of certain biologically active substances and obtain a nal product with a reproducible chemical composition, comparable biological effects, and greater safety for health (Chang & Wasser, 2018).
Although about 270 species of mushrooms have proven medicinal properties, only a few are considered nutraceuticals. Species most commonly found in dietary supplements include Agaricus bisporus (Button mushroom), Ophiocordyceps sinensis (Cordyceps), Ganoderma lucidum (Reishi), Grifola frondosa (Maitake), Hericium erinaceus (Lion’s mane), Lentinula edodes (Shiitake), and Trametes versicolor (Turkey tail) (Niego et al.,
2021). Further study of the biological properties of mushrooms will signicantly expand the list of potential candidates that can be classied as nutraceuticals.
Medicinal mushrooms have been used for thousands of years in traditional oriental medicine for the treatment and prevention of various diseases without side effects (Hobbs, 2023; Zhang et al., 2022). Using modern methods, many secondary metabolites such as polysaccharides, proteins and their complexes, phenolic compounds, polyketides, triterpenoids, steroids, alkaloids, and nucleotides have been isolated and identied
402 Wild Edible Plants
from fruiting bodies, mycelium, and culture liquid of fungi. Some compounds have antidiabetic, antioxidant, antitumor, immunomodulatory, antimicrobial, and antiviral effects (Chang & Wasser, 2018; Niego et al., 2021, 2023; Sandargo et al., 2019). The presence of a large spectrum of biological active compounds in mushrooms can be explained by the fact that in nature, the development of fungal organisms occurs in direct contact with the environment. Therefore, they are constant objects of stressors of a physical and chemical nature. External factors such as the absence or excess of a specic food source, adverse lighting and temperature conditions, changes in the gas composition of the environment, and mechanical damage to the mycelium trigger stress response processes. Under natural conditions, the survival of mushrooms under stress is the rule rather than the exception. During evolution, fungi have developed survival strategies by creating barrier systems and synthesizing numerous bioactive metabolites that allow them to survive in their natural environment (Hyde, 2022).
The primary method of growing macromycetes currently remains solid- phase cul­tivation for fruiting bodies production, but this is a long and labor- intensive process (Arya & Rusevska, 2022; Dedousi et al., 2023; Nikšić et al., 2022; Stabnikova et al.,
2010). The most promising technology for rapidly and efciently producing mushroom mycelium and valuable metabolites from edible and medicinal mushrooms is submerged cultivation in bioreactors (Bakratsas et al., 2021; Berovic & Zhong, 2022a). Cultivation of mushrooms in a submerged state has signicant industrial potential. However, its success on a commercial scale depends on the development of technological stages for intensifying the process of obtaining the nal product, including the use of environmen­tally friendly regulators of the biosynthetic activity of the producing fungus (Berovic & Zhong, 2022a, 2022b, 2023). The creation of new technologies involves an in- depth study of the factors regulating the functions of the fungal organism, which will make it possible to use their natural potential with the most excellent efciency and ensure the obtaining of products of the required quality in the required quantity.
Light is one of the environmentally friendly regulators of morphogenesis, biosyn­thetic, and biological activity of producing macromycetes (Kojima et al., 2015; Nakano et al., 2010; Yue et al., 2022). Understanding the inuence of light on the physiology and metabolism of macromycetes may positively impact the development of bioprocesses that focus on the targeted synthesis of specic bioactive compounds.
Studying the mechanisms of fungal photoreactions is a complex task, both from a fundamental and practical point of view. Knowledge of a producer’s photoreception mechanisms is an integral part of the targeted photoregulation of its activity in biotech­nological processes.
For most macromycetes, light is an essential source of temporal and spatial infor­mation regarding environmental changes (Wang et al., 2016). In addition, it can indicate various environmental stresses such as exposure to genotoxic ultraviolet radiation (UV), oxidative stress, increased temperature, or decreased humidity (Fuller et al., 2016; Yu & Fischer, 2019).
For decades, reactions to light have been studied in at least 100 species of fungi from different systematic groups. Particular attention was paid to the study of the per­ception of light signals by fungi and their transformation into morphological, physio­logical, and metabolic reactions. The mechanisms by which fungi perceive blue, near- UV, green, and red light have been studied (Corrochano, 2007, 2019; Corrochano
Regulation of the Biological Activity of Medicinal Macromycetes 403
& Galland, 2006). It has been established that the processes of spore germination, devel­opment and growth of mycelium, and formation of fruiting bodies can be controlled by lighting conditions (Corrochano, 2007, 2019; Corrochano & Galland, 2006; Fischer et al., 2016; Idnurm et al., 2010; Igbalajobi et al., 2019; Yu & Fischer, 2019; Yu et al.,
2021). Moreover, although a massive amount of information has been accumulated over the last century on various aspects of photoreception and signal transduction by fungi, issues of photoregulation of specic physiological reactions, such as changes in metabolism, are multidimensional processes that require further research. Once basic science has identied the signaling pathways that control, for example, the biosynthetic activity of a producing fungus, applied science can develop physical or genetic means by which these pathways can be regulated and the yield of the desired end product can be increased.
14.2 MECHANISMS OF FUNGAL PHOTORECEPTION
During evolution, fungi formed the photoregulatory system mycochrome. A distinctive feature of this system is the dependence of some stages of morphogenesis and physi­ology on the duration and intensity of exposure to light (Rodriguez- Romero et al., 2010). The reactions of various types of fungi to light began to be studied more than 150 years ago. They can be rapid, such as phototropism, or take a certain time. Light- induced reactions in fungi can be triggered by very brief exposure (nanoseconds to minutes) to low- intensity light (Corrochano, 2007). The long- term effects of light depend pri­marily on genetic reprogramming of the fungal genome and typically involve signicant changes in gene expression patterns. The main question is how much- coordinated acti­vation and repression of hundreds of genes is achieved (Fischer et al., 2016).
The issues of photoreception of light energy in the mycelium and the mechanisms of reactions that occur after light absorption are quite complex and are still being inten­sively studied. It is currently known that light sensors in fungi are chromoproteins, which are low molecular weight compounds that absorb light in certain parts of the spectrum and initiate protein reactions. Some photoreceptive proteins with diverse structures, mechanisms of action, and photosensitivity have been identied in fungi (Galindo et al., 2022). Photoreceptors are specialized proteins or protein complexes that are capable of catching light, generating a signal that travels into the cell and stimulates a cellular response. Their light- absorbing cofactors, known as chromophores, are het­erocyclic organic molecules capable of capturing photons of light (Herrera- Estrella & Horwitz, 2007). Fungal photoreceptors often have multiple protein domains with different functions. Typically, a photoreceptor domain is either attached to a chromo­phore or is near a chromophore, which, when illuminated, can establish a chemical bond with that domain (Bayram & Bayram, 2023). The rst step in light perception is a physical reaction, the absorption of photons by an organic chromophore molecule, which triggers a light- dependent signaling pathway that causes protein conformational changes and transduction into biochemical reactions affecting gene expression in the
404 Wild Edible Plants
body (Fischer et al., 2016). Different fungal photoreceptors respond to different light signals across a wide range of wavelengths. Four types of different light receptors have been identied: blue light, UV light, green, and red- light receptors, which are capable of sensing short, medium, and long wavelengths of light (Bayram & Bayram, 2023; Wang et al., 2016). Currently, the following types of blue light receptor families have been established: White Collars, Vivid, Cryptochrome, and Photolyase (Bayram & Bayram, 2023; Corrochano, 2019). White Collar (WC) proteins are the most studied fungal light receptors. The second group of blue light photoreceptors is Vivid protein (VVD), which is not widely distributed in the fungal kingdom. The third group of blue light receptors in fungi are proteins of the cryptochrome family, photolyase, which were discovered only in the 90s of the twentieth century. Their function is still poorly under­stood compared to WC and VVD.
The initial breakthrough in the molecular understanding of phototransduction in fungi occurred when the White Collar- 1 (WC- 1) gene was cloned by chromosomal movement and complementation of mutants (Ballario et al., 1996). WC- 1 is a zinc nger transcription factor that binds to the promoters of light- regulated genes. The second White Collar Protein (WC- 2) is also a GATA- like zinc nger transcription factor (Herrera- Estrella & Horwitz, 2007).
Proteins similar to WC- 1 and WC- 2 have been identied in the genomes of asco- , basidio- , and zygomycetes, many of which are necessary to explain the photoresponse of fungi to light. It has been suggested that WC complexes arose at the early stages of fungal evolution to regulate their photoresponse, as photoreceptors and transcrip­tion factors. Isolation and characterization of photoreceptors in various macromycete species are based on the previously identied WC- 1 and WC- 2 genes of Neurospora crassa (Linden & Macino, 1997; Talora et al., 1999).
Ambra et al. (2004) studied the photomorphogenesis of the ascomycete Tuber
borchii. The TbWC- 1 gene, homologous to the blue light photoreceptor in Neurospora crassa NcWC- 1 (White Collar- 1), which consists of a light- oxygen- voltage (LOV)
domain and a transcription factor fragment, was identied and cloned. The amino acid sequence of the gene (TbWC- 1) showed high domain similarity with NcWC- 1, except for the polyglutamine regions. It has been established that TbWC- 1 mRNA is controlled by blue light, and its steady- state level increases upon irradiation. In silico analysis of the TbWC- 1 sensor domain (LOV) supports the hypothesis that TbWC- 1 is a blue light photoreceptor (Ambra et al., 2004). Also, genes responsible for blue light photoreceptors have been identied in the basidiomycetes Coprinopsis cinereus and Lentinus edodes.
Terashima et al. (2005) studied the effect of light on the formation of fruiting bodies of the basidiomycete Coprinopsis cinereus. As a result, the Dst1 gene was cloned, which is a 1,175 amino acid protein containing two PAS (Per- Arnt- Sim) domains, a helical structure, and a putative glutamine- rich transcriptional activation domain (AD). One of the PAS domains showed signicant similarity to LOV domains, which are known blue light receptors, suggesting that Dst1 is a blue light receptor in C. cinereus (Terashima et al., 2005).
Later, Sano et al. (2007) cloned and sequenced the photoreceptor gene (Le.phrA) of the basidiomycete Lentinula edodes. The blue light photoreceptor Le.phrA was found to have 924 amino acid residues, and contain a serine- rich region, a LOV domain, and two PAS (Per- Arnt- Sim) domains. It was smaller than other LOV domain- containing
Regulation of the Biological Activity of Medicinal Macromycetes 405
fungal blue light photoreceptors such as Coprinopsis cinerea Dst1, and Neurospora crassa WC- 1 (1,167 aa). It was found that the Le.phrA gene is transcribed at all stages
of forming the fruiting body of L. edodes, but it was most actively transcribed in the immature fruiting body (Sano et al., 2007).
Kanda et al. (2007) identied photoregulated genes that control enzymatic activity, in particular tyrosinases of such macromycete species as Polyporus arcularius, Lentinula edodes, and Agaricus bisporus (Kanda et al., 2007). Nakano et al. (2010) rst identi - ed 15 genes with increased and 13 with decreased regulation of the photoresponse to blue light in the mycelium of the fungus Pleurotus ostreatus (Nakano et al., 2010). In addi tion, most fungal genomes contain genes for other photoreceptors. Sensitivity to red light is realized in fungi by phytochrome, a molecule that until recently was considered unique to plants (Rodriguez- Romero et al., 2010; Wang et al., 2016). This type of photoreceptor, which is responsible for red and far- red light, was rst discovered in two model objects Aspergillus nidulans and Neurospora crassa. Phytochromes are large proteins containing several domains for light reception and signal transmission. One of the striking features of phytochromes is that they are not found in vertebrates, but are specic to plants, bacteria, and fungi (Bayram & Bayram, 2023; Navarro et al., 2013).
Retinal- based opsin systems have recently been discovered, the biological functions of which still require study. Opsins are membrane- bound proteins with seven trans­membrane helices that act as green light receptors (Bayram & Bayram, 2023; Yu & Fischer, 2019). They are the main components of vision in vertebrates, including the human eye. However, their role in fungal photoreception has not been fully studied. Based on spectral sensitivity analysis, it was suggested that the photoreceptors of Schizochyllum commune (Yli- Mattila, 1985) and Coprinellus congregatus contain a compound related to avin or a pteridine (Durand & Furuya, 1985), which were also found in Pleurotus ostreatus (Richartz & Maclellan, 1987). It has been suggested that in Favolus arcularius the possible photoreceptor pigments may be neither carotenoids nor avonoids (Kitamoto et al., 1972). However, in macromycete species other than Coprinopsis cinerea, biochemical and/ or molecular studies of putative photoreceptors have yet to be performed.
Opsin systems at fungal have been described in ascomycetes and basidiomycetes, and sequence similarities have allowed three groups of opsins to be distinguished: the rst group of opsin family proteins act as light- dependent proton pumps (Leptosphaeria maculans); a second group similar to the N. crassa sensory opsin, which is expected to be slow- cycling photosensors; the third group (opsin- like proteins) includes the so­called accessory forms of opsin, present in many fungal species (Bayram & Bayram, 2023; Rodriguez- Romero et al., 2010). However, the issue of the light- regulating role of opsins in fungi and the interaction of opsins with other light- sensitive systems remains insufciently studied.
It is now established that fungi can sense near- ultraviolet, blue, green, red, and far- red light using up to 11 photoreceptors and signaling cascades to control a large portion of the genome and thereby adapt to environmental conditions (Yu & Fischer,
2019). Regarding the time of manifestation of photosensitivity of vegetative mycelium, two hypotheses were put forward and tested: photoinduction manifests itself when the mycelium becomes physiologically mature; photoinduction begins when space and nutrition resources are exhausted (Poyedinok, 2013). As a result of the research, the